LHPP Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of LHPP Antibodies for investigating phospholysine phosphohistidine inorganic pyrophosphate phosphatase (LHPP). LHPP Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LHPP plays a critical role in cellular signaling and metabolism, particularly in the regulation of phosphate metabolism. Research has shown LHPP involvement in various physiological processes, making it a significant focus in cancer and metabolic disorder studies. LHPP expression patterns and activity levels can serve as valuable indicators for disease progression and treatment response. Investigating LHPP function continues to reveal new insights about its role in cellular processes and disease mechanisms. Understanding LHPP regulation and activity provides opportunities to develop novel therapeutic strategies. Researchers worldwide rely on Santa Cruz Biotechnology monoclonal antibodies to advance scientific understanding of LHPP and its potential applications in medicine.